The Global Vaccine Adjuvants Market is expected to grow by USD 401.94 million accelerating at a CAGR of almost 11% during the forecast period. Technavio evaluates the market with a detailed investigation into the market forces, emerging trends, and growth drivers. It also provides competitive benchmarking to equip clients with actionable insights that will help them navigate through the current market scenario. Preview our latest report with COVID-19 Impact Analysis
An adjuvant is an ingredient used in some vaccines that helps to create a stronger immune response in people receiving the vaccine. Adjuvants, thus help the body to produce an immune response strong enough to protect the person from the disease he or she is being vaccinated against. In the wake of the current pandemic and the global scale effort towards developing a potent vaccine is likely to drive the market for vaccine adjuvants over the forecast period
"The development of nanoparticle adjuvants will drive the growth prospects for the Global Vaccine Adjuvants Market in the forthcoming years.Nanoparticle adjuvants intensify an individual’s specific immune responses against pathogen infections and malignancy 55% of the market growth will originate from North America during the forecast period", says senior research analyst for the Health Care Industry at Technavio.
Vaccine Adjuvants Market: Application Segment Highlights
Vaccine Adjuvants Market: Competitive Analysis
Technavio provides custom research reports with detailed insights on the impact of COVID-19 with respect to the industry, region, and supply chain operations. This customized report will help clients keep up with new product launches in direct & indirect COVID-19 related markets. It will also provide insights on upcoming developments along with pipeline analysis of vendor operations and the impact of government regulations. Download a Free Sample Report